Thanks for dropping by to our website. Both at our clinical research facilities and at the Hospital, we are all about ‘WELLNESS’. At JCDC, it is our constant endeavor to bring innovative and world class cures through all our clients – to help society. We support this by engaging in the highest level of ethical standards and with a great degree of emphasis on patient care and well being.
We are a young and dynamic team bringing enthusiasm and passion to provide quality services. We make it a point to partner our clients so that they consider us as an extension of their organization. We look forward to work with you!
As a gesture and our contribution to society JCDC has conducted this study at our center for no charge i.e. pro bono. Have waived all professional fees for the conduct of this study.
For more details see the video https://youtu.be/p1mBM0MHe5Q
It is our honour at Jehangir Hospital and JCDC was chosen as a centre by Indian Council of Medical Research (ICMR) and Serum Institute for the prestigious Covishield Oxford Astra Zeneca Covid-19 vaccine study. (CTRI/2020/08/027170).
Dr. Kiranjit Singh is the Principal Investigator and Dr. Piyush Chaudhari is the Co-investigator of the Covishield study. We are privileged to be part of this study and are happy that Covishield has received Government approval and that our work has borne fruit.